News

The missing step in the formation of a lipid molecule that allows certain single-celled organisms to survive the most extreme environments on Earth has now been deciphered.

Researchers at the University at Buffalo and their collaborators have developed powerful new ways to study and potentially reverse the cellular mechanisms that cause mitochondrial diseases and premature aging.

With super-resolution imaging, Penn Medicine researchers discovered that cells change the physical structure of their genome when they’re affected by disease.

Researchers have developed a new method for studying age-related brain disorders.

Scientists devise novel methods in their microfluidic technology to produce optimized platforms for tissue and disease modeling.

A new study has reported that a novel member from a class of anti-diabetes drug could be used to treat a muscle wasting disease by suppressing inflammation.

A clinical trial has revealed that supplementation with GlyNAC – a combination of glycine and N-acetylcysteine – improves a range of symptoms associated with aging, including inflammation and insulin resistance.

Researchers have successfully engineered human immune cells to model an infection common among immunocompromised children in a breakthrough discovery, paving the way for new drug testing and treatments.

Researchers present a novel approach to single-cell RNA sequencing (scRNA-seq) called “Live-seq”, which enables the extraction of mRNA from single cells without killing the cell. The method is published in Nature.

Newly developed technology has revealed the impact of environmental conditions on the dynamic structures of RNAs in living cells.